News

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...
Prasad, a longtime critic of the FDA’s leniency in drug approvals, joined the agency in May. WASHINGTON — The Food and Drug ...
Prasad came to the Food & Drug Administration in May, hoping to set high, evidence-based standards for new medicines. He didn't even last three months. The industry's power has never been clearer.
Donald Trump's controversial ally Laura Loomer has set up a tip line for administration staff frustrated by a lack of vetting ...
Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts.
Loomer’s outsized influence with the president came under heightened scrutiny in April after she reportedly encouraged him to oust Gen. Timothy Haugh, the head of the National Security Agency and U.S.
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
On the 2024 campaign trail, President Trump promised to “end inflation” and increase affordability, while touting economic ...
A $1.26 billion contract to build the nation’s largest detention center was awarded to a little-known Virginia company—which ...
WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has ...
This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...